US2010121061A1PendingUtilityA1
Compounds capable of activating cholinergic receptors
Est. expiryJun 16, 2018(expired)· nominal 20-yr term from priority
Inventors:William Scott CaldwellGary Maurice DullBalwinder Singh BhattiSrishailkumar B. HadimaniHaeil ParkJared Miller WagnerPeter A. CrooksPatrick M. LippielloMerouane Bencherif
A61P 43/00C07D 213/73A61P 25/22A61P 29/02A61P 25/04A61P 25/00C07D 239/26A61K 31/505C07D 213/61A61P 25/28C07D 213/65A61K 31/44C07D 213/38C07D 403/06A61P 25/18A61P 25/14
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention generally relates to nicotinic compounds, in the form of aryl substituted olefinic compounds, as well as pro-drug, N-oxide, metabolite and pharmaceutically acceptable salt forms thereof. Methods of modulating neurotransmitter release via administration of the compounds, pro-drugs, N-oxides and/or pharmaceutically acceptable salts are also disclosed.
Claims
exact text as granted — not AI-modified1 . A method for synthesizing a compound of formula
or a pharmaceutically acceptable salt thereof, wherein
each of A, A I , and A II is H;
X is COR I ;
R I is C 1-5 alkyl;
X I is N;
m is 1;
n is 1;
each of E I , E II , E III , E IV , and E V is H;
E VI is C 1-5 alkyl; and
each of Z I and Z II individually is H or C 1-5 alkyl;
comprising coupling of a halo-substituted pyridine with an olefin containing a secondary alcohol functionality.
2 . The method of claim 1 , wherein
each of A, A I , and A II is H; X is COR I ; R I is isopropyl; X I is N; m is 1; n is 1; each of E I , E II , E III , E IV , and E V is H; geometry about the depicted wavy line is E; E VI is methyl; Z I is H; and Z II is methyl.
3 . The method of claim 2 , wherein the halo-substituted pyridine is 3-bromo-5-isopropoxypyridine.
4 . The method of claim 3 , wherein the olefin containing a secondary alcohol functionality is 4-penten-2-ol.
5 . The method of claim 5 , further comprising converting to a p-toluenesulfonate ester by treating with p-toluenesulfonyl chloride.
6 . The method of claim 5 , further comprising treating with methylamine.
7 . A method for synthesizing a compound of formula
or a pharmaceutically acceptable salt thereof, wherein
each of A, A I , and A II is H;
X is COR I ;
R I is C 1-5 alkyl;
X I is N;
m is 1;
n is 1;
each of E I , E II , E III , E IV , and E V is H;
E VI is C 1-5 alkyl; and
each of Z I and Z II individually is H or C 1-5 alkyl; comprising coupling of a halo-substituted pyridine with an olefin containing a protected amine functionality.
8 . The method of claim 7 , wherein
each of A, A I , and A II is H; X is COR I ; R I is isopropyl; X I is N; m is 1; n is 1; each of E I , E II , E III , E IV , and E V is H; geometry about the depicted wavy line is E; E VI is methyl; Z I is H; and Z II is methyl.
9 . The method of claim 8 , wherein the halo-substituted pyridine is 3-bromo-5-isopropoxypyridine.
10 . The method of claim 9 , wherein the olefin containing a protected amine functionality is N-methyl-N-(tert-butoxycarbonyl)-4-penten-2-amine.Join the waitlist — get patent alerts
Track US2010121061A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.